IMBRIA
Live / Registered — Registered (as of 23 Jan 2024)
What this means for you
Registered since 23 Jan 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88193544
- Registration number
- 7287486
- Mark type
- Stylized text
- Filed
- 14 Nov 2018
- Published for opposition
- 28 Feb 2023
- Registered
- 23 Jan 2024
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 042 — Scientific and technological services: Research and development for pharmaceuticals
Owner
- Imbria Pharmaceuticals, Inc., Boston, MA, US
- Imbria Pharmaceuticals, Inc., Boston, MA, US
- Imbria Pharmaceuticals, Inc., Boston, MA, US
Prosecution history
- 23 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 Jan 2024 — REGISTERED-PRINCIPAL REGISTER
- 19 Dec 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 18 Dec 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Nov 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 25 Oct 2023 — USE AMENDMENT FILED
- 06 Nov 2023 — SOU EXTENSION 1 GRANTED
- 25 Oct 2023 — SOU EXTENSION 1 FILED
- 30 Oct 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 Oct 2023 — SOU TEAS EXTENSION RECEIVED
- 25 Oct 2023 — TEAS STATEMENT OF USE RECEIVED
- 25 Apr 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Feb 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Feb 2023 — PUBLISHED FOR OPPOSITION